Maximum quantity allowed is 999
请选择数量
CAS RN: 97322-87-7 | 产品编码: T3920
Troglitazone

技术规格
Appearance | White to Orange to Green powder to crystaline |
Purity(HPLC) | min. 98.0 area% |
物性(参考值)
熔点 | 177 °C |
GHS
相关法规
RTECS# | XJ5813130 |
运输信息
HS编码* | 2934.10-000 |
应用
Troglitazone: An Agonist at the Peroxisome Proliferator-Activated Receptor of the Gamma Subtype (PPARγ)
Troglitazone (CS-045), a thiazolidinedione such as rosiglitazone [R0106] and pioglitazone [P1091 (HCl salt)], is an agonist at the peroxisome proliferator-activated receptor of the gamma subtype (PPARγ), a transcription-regulating receptor.1) PPAR receptors are found in peripheral tissues important for insulin action. Activation of PPARγ nuclear receptors modulates the transcription of a number of insulin responsive genes involved in the control of glucose and lipid metabolism. Therefore, troglitazone decreases insulin resistance in the periphery tissues and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. In addition, the PPARγ-independent antitumor effects of troglitazone has been reported.2) Troglitazone was developed as the first in the thiazolidinedione class of hypoglycemic agents, but it was later withdrawn from the pharmaceutical market due to hepatotoxicity.3,4) (The product is for research purpose only.)
References
- 1) The mode of action of thiazolidinediones (a review)
- 2) PPARγ-independent antitumor effects of thiazolidinediones (a review)
- 3) Lessons from the glitazones: a story of drug development (a review)
- 4) Mechanisms of troglitazone hepatotoxicity (a review)
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。